dc.contributor.author | Uzunhan, Tugce Aksu | |
dc.contributor.author | Bektas, Gonca | |
dc.contributor.author | Caliskan, Mine | |
dc.contributor.author | Yildiz, Edibe | |
dc.contributor.author | YEŞİL, GÖZDE | |
dc.contributor.author | Ozkan, Melis Ulak | |
dc.date.accessioned | 2021-03-03T16:18:27Z | |
dc.date.available | 2021-03-03T16:18:27Z | |
dc.identifier.citation | Bektas G., YEŞİL G., Ozkan M. U. , Yildiz E., Uzunhan T. A. , Caliskan M., "Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up.", Clinical neurology and neurosurgery, cilt.171, ss.190-193, 2018 | |
dc.identifier.issn | 0303-8467 | |
dc.identifier.other | av_4382a5cb-2bd6-4434-984f-39557ff27774 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/49097 | |
dc.identifier.uri | https://doi.org/10.1016/j.clineuro.2018.06.023 | |
dc.description.abstract | Background: Vanishing white matter disease is a heterogeneous disorder caused by mutation in one of the five genes encoding subunits of the eukaryotic initiation factor eIF2B. It is a heterogeneous disorder due to phenotypic variation and a clear genotype-phenotype correlation could not be established so far. We describe a novel mutation in the EIF2B5 gene by analyzing the clinical phenotype and the progression of brain lesions for 10 years. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | CERRAHİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Vanishing white matter disease with a novel EIF2B5 mutation: A 10-year follow-up. | |
dc.type | Makale | |
dc.relation.journal | Clinical neurology and neurosurgery | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 171 | |
dc.identifier.startpage | 190 | |
dc.identifier.endpage | 193 | |
dc.contributor.firstauthorID | 255113 | |